{"name":"Kwang Dong Pharmaceutical co., ltd.","slug":"kwang-dong-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Vitamin D3 B.O.N. Injection","genericName":"Vitamin D3 B.O.N. Injection","slug":"vitamin-d3-b-o-n-injection","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Vitamin D3 B.O.N. Injection","genericName":"Vitamin D3 B.O.N. Injection","slug":"vitamin-d3-b-o-n-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-01","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9WVm9kWEZxOVNPd3A3T1lhSXRoV2YyRkEyU2ltY010cWtRVkNvU3NQTE9NajFrbWs4VnRrdDFBVmhRTTFybXNMRWxUc0tZNkxaamVsazg1YVpfVnJ5OURnVFhpY0hKbUVlYkh5elItS2NYSHRY?oc=5","date":"2026-02-19","type":"regulatory","source":"Businesskorea","summary":"Kwang Dong Pharma Surges on FDA Approval of Eye Treatment - Businesskorea","headline":"Kwang Dong Pharma Surges on FDA Approval of Eye Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTE51c2VlckMtdUczblhQLWx4OEhFX3NrSzBYQlF1TXM5TjR2N0lYMDZIT01PWU1faU9KbjRkbl9CTF83UQ?oc=5","date":"2025-12-24","type":"pipeline","source":"코메디닷컴","summary":"As Parliament Drags Its Feet, Kwangdong Pharmaceutical, Daewoong, and Humedix Swap Treasury Shares - 코메디닷컴","headline":"As Parliament Drags Its Feet, Kwangdong Pharmaceutical, Daewoong, and Humedix Swap Treasury Shares - 코메디닷컴","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNS2psYWNHa21ZM3JFMFh3eUJfdHMxMTVTc0RRemh1ZmlMLTRpY0VnRXFfVUExbWZmMXNlVXlCV0xVRU5GNUcwNTVLb0ZGb1UxdGxhWEhFT3ItalEtX09DOWZPU0FvNjZNVEdQSUpIb01DZU5KUk00TE5mTEJwYjR5STV4WTVEQWs0WDhEVnFnN1pBbXdfR0JwcFRCNVIyNUZPWmpDRHdqU094cFd3Nm11MDJHRS1NYmFBY3NOd0pvaWxEdkJzWUxUSjZaTnhuYjVmVkY2R2FDUzQ2R1dmVlR1SURtQld5X2RkcVcyRk95Vm5mX092a2hhbmR3bVFnNG9EWDJGVU4yWFRfbGRuX2xDZG5VdUQ0aEtOVUs4MU83WkMwaGRxbnlpc2o0bG5ZWjg?oc=5","date":"2025-11-05","type":"pipeline","source":"businesswire.com","summary":"Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia to the MFDS in South Korea - businesswire.com","headline":"Tenpoint Therapeutics Ltd. Announces Submission of a New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOVlNJQ2ttSjhmZFdtcGstdUVRaFdnVUFWbFJmeThBWF9Ma2tJR2pkTE1FV3BTNUJfZm9wOXJWd0lwMjlvbVNUSXJyS0kwS2ZOT2xrS196bUpfVDRMa2E4b0pTQmxDaUc4ek1BOUlINGpHRHgzcm9OQlFUVzhTZ3o1NmZBd3VSanBHUUtTU0NMa2MzZlZnOVVERU5oYnVKdmxIcUtscXJ5WkRtMUZHcl8wdXRNcTZvN0t6ckNMbW1R?oc=5","date":"2025-09-15","type":"deal","source":"Ocugen, Inc.","summary":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - Ocugen, Inc.","headline":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNNUFfYmZrbzhxLU13c25mV1dnancyNlZnLUE3eC1yZDJJd1Y5T0lEai03Skt1cUc1Q1BnZ1hYMVd1bEMzVmZLcldhT1phVGVoT0xhSzRfeEI0OEpXUHdzNUROMi1vOHNON1p3RjRuOVdEYVB5aks0RDJwSm9qcXNJSl8wN1ZGOHBiRnZyVzZyNjd1UkZBZWlMaU9KNmROUVB1?oc=5","date":"2025-09-15","type":"deal","source":"The Business Journals","summary":"Ocugen shares soar on gene therapy deal with Korean pharma giant - The Business Journals","headline":"Ocugen shares soar on gene therapy deal with Korean pharma giant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPN2F4ZUl2RE1lOENPVlB3UVZMTmNHTXpnVUlMU2FYdFRIX00zNm9vdUtDWlVrYVFrZ0d4N0xuOHRfYVo1aWVxNHYwbkNBcHZnZ2VET0Ruck5XQ0labGNFSGtkcF8yVURDU2RoUkxOMVhOaHNOVmdvREdZQlZ2RGd2X09qWXZuUWR0Y1B0LXZRQUw4RG5lUW92R1BIeEx6ZGQwMmV5UW5HWXFFdU5ucnlvM1YyNVl6RTVia1I3Z000RQ?oc=5","date":"2025-09-15","type":"pipeline","source":"Ophthalmology Times","summary":"Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea - Ophthalmology Times","headline":"Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9uRjkzUlNTMTA3M2FEVlQ2MWZCX1MwaUp4eHJaYkhVN1BadDl1M3Zjb040ZGhBQTJvVG9BOUtuWU9rM0N1eFJ1dXplYlFuZkJBd25JYlQzZTEzWGhLeDR3bVBjWUQ4eWJQanYyVUNB?oc=5","date":"2024-07-03","type":"deal","source":"KED Global","summary":"Kwangdong Pharma acquires stake in Precision Bio - KED Global","headline":"Kwangdong Pharma acquires stake in Precision Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1zYnU5bTg5NTQyZk9LSXItQUQzdlBsMUJBR29uTUJMUTgtQjYwb2RhaV9fZ3hoMHJBSzI5akhhUU5mc19TcEwzNkVjVElKdUgxMng4ZzltMG41NmI0ZlpIUDRfZV90QmNON1ZjRzF30gFyQVVfeXFMUGhtSnNhcHRUelU5ck1EQW1KUXM4Z29uNEhnZ3VOV05xa3FwazlkUmh2eHVZMHotdDlkbkxSZ3hCLUVQTXE4anlaY0RZR1FPS2x5YWpnZTRFUHVOeThKVjNTZC1LTVJBaDBHb2YyZE5WSkd3?oc=5","date":"2024-01-02","type":"pipeline","source":"koreabiomed.com","summary":"BL Pharmtech sells subsidiary BL Healthcare to Kwangdong to focus on drug development - koreabiomed.com","headline":"BL Pharmtech sells subsidiary BL Healthcare to Kwangdong to focus on drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5LZnY1SXdoSUxUdUg5VkUzdkFJdGdxalhnOHlUdTB1YzB3cW50cTlfNUs2LTkxV24zU2s3ZnFVeUd0QXpqYkttNVI2ZDBoRzhVc3JZaEFBdC1BNVQwakNEWURhdHIxeWl1c0NIVllB0gFyQVVfeXFMUEZlVWw4dmxNclhKSFMyd3hQRXJqSTJJMndwYjFnREVwX1l1cGpkaTlUVlUwOWx4UV9XeVFZN2ROWl9LVzVBVU15SHpQSTB4UXJ2XzgxanUzT0NmczdOUmNjTVlVdWZOeTJTbDlVQmM4dWxn?oc=5","date":"2023-12-05","type":"pipeline","source":"koreabiomed.com","summary":"Kwangdong to expand health functional food biz through acquisition of BL Healthcare - koreabiomed.com","headline":"Kwangdong to expand health functional food biz through acquisition of BL Healthcare","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5sYWQ4Ykt4WWdZMEhnRFNnRzZjem1KTWhIbU55MUF4dk9OU0pBYS1vdFU1Rk9Ub1Z5WkxBMG5JbjFaMnNBZGk0NkVPcmpBZHpVZW5BU0ZOSWgtNFEycVlERGxtQkgtck5Kd3RSWXZn?oc=5","date":"2023-07-24","type":"pipeline","source":"KED Global","summary":"Kwangdong to sell exclusively three global rare disease drugs - KED Global","headline":"Kwangdong to sell exclusively three global rare disease drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVmhyLVNGaHd0YTJKZ29MakRzN2Q5SmRhN2NHNXZ2clpOWGllRDlaR0JkX1hwbnAwSEdJdGViX1lmVDd2aGVqZEdRTzBLZnZvS1BuUEZqaXVDajVIakpabWE3bXdHMHBvQ2dyWlZTWU9RWDE2SzZGRDdVU0dNNU5sOF9fMVE2SldvajFfQlZNQQ?oc=5","date":"2020-08-19","type":"pipeline","source":"marketscreener.com","summary":"Kwang Dong Pharmaceutical Co., Ltd.: Shareholders Board Members Managers and Company Profile | KR7009290008 - marketscreener.com","headline":"Kwang Dong Pharmaceutical Co., Ltd.: Shareholders Board Members Managers and Company Profile | KR7009290008","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}